| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
48,440,000 |
| Market
Cap: |
656.85(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$10.35 - $19.75 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 8.1 |
| Insider 6 Months : 8.1 |
| Insider 3/6 Months : 16.5 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing vaccines. Co.'s initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. HIL-214 consists of VLPs which are designed to mimic the structure of norovirus and are co-formulated with an alum adjuvant to improve immunogenicity and stability of the VLPs in solution. VLPs are self-assembling structures that mimic the certain and repetitive geometric features that characterize the surface of a live virus. HIL-214 comprises VLPs for the two major genotypes of norovirus: GI.1 and GII.4.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
10,100 |
10,100 |
10,100 |
1,774,806 |
| Total Buy Value |
$149,550 |
$149,550 |
$149,550 |
$30,149,552 |
| Total People Bought |
2 |
2 |
2 |
2 |
| Total Buy Transactions |
2 |
2 |
2 |
3 |
| Total Shares Sold |
105,972 |
150,972 |
150,972 |
150,972 |
| Total Sell Value |
$986,915,434 |
$987,562,434 |
$987,562,434 |
$987,562,434 |
| Total People Sold |
4 |
4 |
4 |
4 |
| Total Sell Transactions |
17 |
22 |
22 |
22 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kohli Aditya |
|
– • – |
2024-04-05 |
4 |
AS |
$14.44 |
$86,640 |
D/D |
(6,000) |
789,776 |
|
-12% |
|
| Heron Patrick J |
Director |
– • • |
2024-04-04 |
4 |
B |
$14.50 |
$128,325 |
D/D |
8,850 |
8,544,187 |
3.92 |
-9% |
|
| Kohli Aditya |
|
– • – |
2024-04-04 |
4 |
AS |
$14.71 |
$88,245 |
D/D |
(6,000) |
795,776 |
|
-12% |
|
| Kohli Aditya |
|
– • – |
2024-04-03 |
4 |
AS |
$14.93 |
$89,582 |
D/D |
(6,000) |
801,776 |
|
-14% |
|
| Mcloughlin Sean |
Chief Operating Officer |
• – – |
2024-03-28 |
4 |
B |
$16.98 |
$21,225 |
D/D |
1,250 |
1,250 |
0.01 |
-21% |
|
| Kohli Aditya |
|
– • – |
2024-03-20 |
4 |
AS |
$164,221.00 |
$985,326,000 |
D/D |
(6,000) |
807,776 |
|
-21% |
|
| Kohli Aditya |
|
– • – |
2024-03-19 |
4 |
AS |
$17.42 |
$104,492 |
D/D |
(6,000) |
813,776 |
|
-27% |
|
| Kohli Aditya |
|
– • – |
2024-03-18 |
4 |
AS |
$17.66 |
$105,937 |
D/D |
(6,000) |
819,776 |
|
-26% |
|
| Kohli Aditya |
|
– • – |
2024-03-08 |
4 |
AS |
$18.66 |
$111,959 |
D/D |
(6,000) |
825,776 |
|
-31% |
|
| Kohli Aditya |
|
– • – |
2024-03-07 |
4 |
AS |
$18.37 |
$110,213 |
D/D |
(6,000) |
831,776 |
|
-31% |
|
| Kohli Aditya |
|
– • – |
2024-03-06 |
4 |
AS |
$18.95 |
$113,701 |
D/D |
(6,000) |
837,776 |
|
-32% |
|
| Kohli Aditya |
|
– • – |
2024-02-22 |
4 |
AS |
$15.05 |
$90,312 |
D/D |
(6,000) |
843,776 |
|
-15% |
|
| Kohli Aditya |
|
– • – |
2024-02-21 |
4 |
AS |
$14.92 |
$89,495 |
D/D |
(6,000) |
849,776 |
|
-15% |
|
| Kohli Aditya |
|
– • – |
2024-02-20 |
4 |
AS |
$14.88 |
$89,272 |
D/D |
(6,000) |
855,776 |
|
-15% |
|
| Kohli Aditya |
|
– • – |
2024-02-12 |
4 |
AS |
$15.32 |
$91,921 |
D/D |
(6,000) |
861,776 |
|
-17% |
|
| Hershberg Robert |
See Remarks |
• • – |
2024-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
174,202 |
1,128,033 |
|
- |
|
| Hershberg Robert |
See Remarks |
• • – |
2024-02-08 |
4 |
S |
$14.93 |
$173,161 |
D/D |
(11,597) |
953,831 |
|
12% |
|
| Kohli Aditya |
|
– • – |
2024-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
54,898 |
867,776 |
|
- |
|
| Kohli Aditya |
|
– • – |
2024-02-08 |
4 |
S |
$14.93 |
$132,383 |
D/D |
(8,866) |
812,878 |
|
12% |
|
| Maltbie Shane |
Chief Financial Officer |
• – – |
2024-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
47,522 |
88,178 |
|
- |
|
| Maltbie Shane |
Chief Financial Officer |
• – – |
2024-02-08 |
4 |
S |
$14.93 |
$53,395 |
D/D |
(3,576) |
40,656 |
|
12% |
|
| Borkowski Astrid |
Chief Medical Officer |
• – – |
2024-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
53,632 |
214,892 |
|
- |
|
| Borkowski Astrid |
Chief Medical Officer |
• – – |
2024-02-08 |
4 |
S |
$14.93 |
$58,726 |
D/D |
(3,933) |
161,260 |
|
12% |
|
| Borkowski Astrid |
Chief Medical Officer |
• – – |
2023-12-15 |
4 |
S |
$15.50 |
$155,000 |
D/D |
(10,000) |
165,193 |
|
9% |
|
| Borkowski Astrid |
Chief Medical Officer |
• – – |
2023-12-04 |
4 |
S |
$14.50 |
$145,000 |
D/D |
(10,000) |
175,193 |
|
5% |
|
46 Records found
|
|
Page 1 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.36 (2.73%) 
